Silencing of TRIM44 Inhibits Inflammation and Alleviates Traumatic Brain Injury in Rats by Downregulating TLR4-NF-κB Signaling
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Background: Neuroinflammation subsequent to traumatic brain injury (TBI) is important for the recovery of patients and is associated with neurodegenerative changes post-TBI. The tripartite motif containing 44 (TRIM44) protein is an E3 ligase involved in the regulation of immune function with no previously known link to TBI. This study explores the connection between TRIM44 and TBI. Methods: After induction of TBI in rats by control cortex injury, TRIM44 expressions were determined with quantitative real-time reverse transcription polymerase chain reaction and Western blot, and Toll-like receptor 4 (TLR4)-NF-κB signaling was examined by the expression of TLR4, p65 phosphorylation, and the specific NF-κB transcription activity. The effects of TRIM44 knockdown on inflammation, neurological function, and TLR4-NF-κB signaling in TBI rats were revealed by the detection of proinflammatory cytokines and TLR4-NF-κB signaling molecules, modified neurological severity score, brain water content, and Evans blue permeability. Results: We found that TRIM44 expression was significantly increased following TBI induction along with TLR4-NF-κB activation. Silencing of TRIM44 suppressed proinflammatory cytokine production, improved neurological outcomes, alleviated brain edema, and inhibited TLR4-NF-κB signaling in TBI rats. Conclusion: Our findings suggest that suppressing TRIM44 or modulation of relevant pathways may be a therapeutic strategy for TBI.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition to these critical effectors, several members of the AD-specific miR-132 predicted targetome that we identified, e.g. TRIM44, NUCKS1, NFE2L2, LYN, ZEB2, SPRED1, ABHD5, RASA1, and NAP1L1 [143, 147–154], have known roles in inflammation and/or microglial cell states/function.”
From microRNA-132 attenuates inflammation in induced pluripotent stem cell-derived microglia from Alzheimer’s disease patients (2026) · cites this paper as [147]
Citations
Cites
The far-reaching scope of neuroinflammation after traumatic brain injury
Simon, D. W., McGeachy, M. J., Bayır, H., Clark, R. S. B., Loane, D. J., & Kochanek, P. M. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.13 · Cited by 1,190
Clinical evidence of inflammation driving secondary brain injury: A systematic review
Hinson, H. E., Rowell, S., & Schreiber, M. (2015) · Journal of Trauma and Acute Care Surgery · doi:10.1097/ta.0000000000000468 · Cited by 179
Pathological correlations between traumatic brain injury and chronic neurodegenerative diseases
Cruz-Haces, M., Tang, J., Acosta, G., Fernandez, J., & Shi, R. (2017) · Translational Neurodegeneration · doi:10.1186/s40035-017-0088-2 · Cited by 161
Fazel, S., Wolf, A., Pillas, D., Lichtenstein, P., & Långström, N. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.3935 · Cited by 159
TLR2 and TLR4 in the Brain Injury Caused by Cerebral Ischemia and Reperfusion
Wang, Y., Ge, P., & Zhu, Y. (2013) · Mediators of Inflammation · doi:10.1155/2013/124614 · Cited by 153
Self-citationYao, X., Liu, S., Ding, W., Yue, P., Jiang, Q., Zhao, M., Hu, F., & Zhang, H. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.06.006 · Cited by 147
Ahmad, A., Crupi, R., Campolo, M., Genovese, T., Esposito, E., & Cuzzocrea, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057208 · Cited by 143
Sun, Z., Nyanzu, M. K., Yang, S., Zhu, X., Wang, K., Ru, J., Yu, E., Zhang, H., Wang, Z., Shen, J. M., et al. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/7879629 · Cited by 117
Novel Function of Trim44 Promotes an Antiviral Response by Stabilizing VISA
Yang, B., Wang, J., Wang, Y., Zhou, H., Wu, X., Tian, Z., & Sun, B. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202507 · Cited by 116
Jiang, H., Wang, Y., Liang, X., Xing, X., Xu, X., & Zhou, C. (2017) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-017-0570-5 · Cited by 87
Cited by
Penning, A., Snoeck, S., Ormaechea, O. R., Ayyildiz, D., Polzer, O., Buitrago-Arango, M., Capobianco, R., de Winter, F., Balusu, S., Verhaagen, J., et al. (2026) · Acta Neuropathologica Communications · doi:10.1186/s40478-026-02228-8 · Cited by 6
Kang, J., Zhou, Y., Xiong, Q., & Dong, X. (2024) · Aging · doi:10.18632/aging.205795 · Cited by 5
Metadata
- Authors
- Zhu, L., Dong, C., Yue, X., Ge, P., Zheng, G., Ye, Z., & Pan, B.
- Venue
- Neuroimmunomodulation
- Publisher
- S. Karger AG
- Published
- 2022
- Volume
- 29
- Issue
- 4
- Pages
- 439-449
- ISSN
- 1021-7401
- 1423-0216
- Cited by
- 9
- References
- 28
- Language
- en
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Silencing of TRIM44 Inhibits Inflammation and Alleviates Traumatic Brain Injury in Rats by Downregulating TLR4-NF-κB Signaling. https://app.cochat.ai/papers/10.1159/000524536
- The paper
- Zhu, L., Dong, C., Yue, X., Ge, P., Zheng, G., Ye, Z., & Pan, B. (2022). Silencing of TRIM44 Inhibits Inflammation and Alleviates Traumatic Brain Injury in Rats by Downregulating TLR4-NF-κB Signaling. Neuroimmunomodulation. https://doi.org/10.1159/000524536
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.